BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 11, 2000
View Archived Issues
Progenics and Cytogen present preclinical progress on PSMA technology
Read More
M-Vax shown to induce T-cell-mediated immune reactions in metastatic melanoma study
Read More
Oxford GlycoSciences and Pfizer file patent application for AD markers
Read More
New program for bone disease therapy initiated by Aastrom Biosciences
Read More
Sonus signs agreement with SUNY to develop oxygen delivery systems
Read More
Positive results reported for Reminyl in AD therapy
Read More
CollaGenex research reported at international dental meeting
Read More
Zadaxin plus chemotherapy shows promise in malignant melanoma
Read More
Gemini Genomics and Kyowa Hakko discover novel gene for metabolic syndrome
Read More
Bayer obtains first approval worldwide for new antiallergic agent
Read More
Glaxo Wellcome continues research on formamides as inhibitors of MMPs and/or TNF-alpha release
Read More
Formamides from Glaxo Wellcome with potential as antitumor therapeutics
Read More
LeukoSite and Kyowa Hakko collaborate on the design of chemokine receptor antagonists
Read More
New formulation of Hectorol approved by FDA
Read More
Inhibitors of PDE5 claimed in recent patent by Tanabe Seiyaku
Read More
Preclinical study suggests potential for Axonyx compounds in AD
Read More
FDA committee favors approval of new oral treatment for ED
Read More
Novel antidiabetics from Novo Nordisk act as normoglycemic agents
Read More
Prosorba Column launched in Europe for RA
Read More
New antitumor tetrocarcin derivatives in early development at Japanese lab
Read More
Pfizer describes SAR in a series of quinazolinone AMPA antagonists at ACS meeting
Read More
Another setback reported in the elusive search for an effective sepsis therapy
Read More
BMS-184476 and BMS-188797 covered at ACS/AACR meetings; BMS reveals structures
Read More
SuperGen and AVI BioPharma establish marketing agreement for Avicine
Read More
Potent and selective oxindole cdk2 inhibitors display dual antitumor and chemoprotective effects
Read More
Rasagiline successfully completes phase III trial in PD
Read More
Selective inhibitor of chitin II synthase discovered in Korea and evaluated as antifungal agent
Read More
Apligraf PMA supplement tentatively scheduled for FDA review in May
Read More